Home » Monte Rosa Therapeutics, Inc. (GLUE) Discusses GFORCE-1 Phase I Results for NEK7 Molecular Glue Degrader MRT-8102 in Cardiovascular Disease Risk – Slideshow

Monte Rosa Therapeutics, Inc. (GLUE) Discusses GFORCE-1 Phase I Results for NEK7 Molecular Glue Degrader MRT-8102 in Cardiovascular Disease Risk – Slideshow

October 5, 2026October 5, 2026

Bitcoin (BTC) $ 85,955.00

Ethereum (ETH) $ 2,715.69

Tether (USDT) $ 0.999962

XRP (XRP) $ 1.51

BNB (BNB) $ 788.19

Dogecoin (DOGE) $ 0.095566

Solana (SOL) $ 120.81

USDC (USDC) $ 0.999981

Lido Staked Ether (STETH) $ 2,265.05

Avalanche (AVAX) $ 11.08

TRON (TRX) $ 0.336246

Wrapped stETH (WSTETH) $ 2,779.67

Sui (SUI) $ 1.21

Chainlink (LINK) $ 13.86

WETH (WETH) $ 2,268.37

Polkadot (DOT) $ 1.23